Citation Impact
3 from Science/Nature 51 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Works of Daniel LaSala being referenced
Therapeutic administration of inhaled INS1009, a treprostinil prodrug formulation, inhibits bleomycin-induced pulmonary fibrosis in rats
2018
Discovery and in Vivo Evaluation of Potent Dual CYP11B2 (Aldosterone Synthase) and CYP11B1 Inhibitors
2013
Author Peers
| Author | Molecular Biology | EDM | PRM | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| Daniel LaSala | 200 | 120 | 71 | 17 | 436 | |
| Christian Cazares | 19 | 1 | 12 | 265 | ||
| Tarianna Stewart | 10 | 2 | 3 | 9 | 353 | |
| Gaeun Kim | 2 | 4 | 409 | |||
| Matthew Bono | 1 | 24 | 559 | |||
| Eva Marina Reinares Lara | 53 | 587 |
All Works
Loading papers...